Use of PCR analysis for detecting low levels of bacteria and mold contamination in pharmaceutical samples

被引:36
作者
Jimenez, L [1 ]
Smalls, S [1 ]
Ignar, R [1 ]
机构
[1] Block Drug Co, Microbiol Lab, Res & Dev, Jersey City, NJ 07302 USA
关键词
PCR; pharmaceutical samples; microbial contamination;
D O I
10.1016/S0167-7012(00)00164-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
PCR assays were developed and compared to standard methods for quality evaluation of pharmaceutical raw materials and finished products with low levels of microbial contamination. Samples were artificially contaminated with less than 10 CFU of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Aspergillus niger. Bacterial DNA was extracted from each enrichment broth by mild lysis in Tris-EDTA-Tween 20 buffer containing proteinase K while mold DNA was extracted by boiling samples in Tris-EDTA-SDS buffer for 1 h. A 10-mu l aliquot of extracted DNA was added to Ready-To-Go PCR beads and specific primers for E. coli, S. aureus, and P. aeruginosa. However, 50-mu l aliquots of extracted mold DNA were used for amplification of specific A. niger DNA sequences. Standard methods required 6-8 days while PCR detection of all microorganisms was completed within 27 h. Low levels of microbial contamination were detected in all raw materials and products using PCR assays. Rapid quality evaluation of pharmaceutical samples resulted in optimization of product manufacturing, quality control, and release of finished products. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 28 条
[1]  
Baird R, 1998, PHARM MICROBIOLOGY, P374
[2]   DETECTION OF ESCHERICHIA-COLI AND SHIGELLA SPP IN WATER BY USING THE POLYMERASE CHAIN-REACTION AND GENE PROBES FOR UID [J].
BEJ, AK ;
DICESARE, JL ;
HAFF, L ;
ATLAS, RM .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1991, 57 (04) :1013-1017
[3]   BIOLUMINESCENCE FOR USP STERILITY TESTING OF PHARMACEUTICAL SUSPENSION PRODUCTS [J].
BUSSEY, DM ;
TSUJI, K .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1986, 51 (02) :349-355
[4]  
CASEY W, 1998, PHARM TECHNOL, V22, P114
[5]  
COPPI G, 1970, IL FARMACO, V26, P224
[6]  
COPPI G, 1970, FARMACO, V26, P224
[7]  
de la Rosa M C, 1995, Pharm Acta Helv, V70, P227, DOI 10.1016/0031-6865(95)00022-2
[8]  
DESVIGNES A, 1973, ANN PHARM FR, V31, P775
[9]   Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL [J].
DeVos, D ;
Lim, A ;
Pirnay, JP ;
Struelens, M ;
Vandenvelde, C ;
Duinslaeger, L ;
Vanderkelen, A ;
Cornelis, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1295-1299
[10]   A COMPARISON OF 2 INCUBATION TEMPERATURES FOR THE ISOLATION OF GRAM-NEGATIVE CONTAMINANTS FROM RAW-MATERIALS AND NONSTERILE PHARMACEUTICALS [J].
FERGUSON, A ;
PATEL, A ;
BAIRD, RM .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1987, 12 (04) :249-254